Trial Profile
"A phase IIa-IIb placebo-controlled, randomized, clinical trial to assess the efficacy and safety of NASVAC Therapeutic Vaccine Candidate in patients with Chronic Hepatitis B Virus infection"
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Oct 2020
Price :
$35
*